Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
-20° C Freezer
White to Off-White Solid
"Hydrochlorothiazide (abbreviated HCTZ, HCT, or HZT) is a diuretic medication often used to treat high blood pressure and swelling due to fluid build up. Other uses include diabetes insipidus, renal tubular acidosis, and to decrease the risk of kidney stones in those with high calcium level in the urine. For high blood pressure it is often recommended as a first line treatment. HCTZ is taken by mouth and may be combined with other blood pressure medications as a single pill to increase the effectiveness.
Potential side effects include poor kidney function, electrolyte imbalances especially low blood potassium and less commonly low blood sodium, gout, high blood sugar, and feeling faint initially upon standing up. While allergies to HCTZ are reported to occur more often in those with allergies to sulfa drugs this association is not well supported. It may be used during pregnancy but is not a first line medication in this group.
It is in the thiazide medication class and acts by decreasing the kidneys' ability to retain water. This initially reduces blood volume, decreasing blood return to the heart and thus cardiac output. Long term, however, it is believed to lower peripheral vascular resistance.
Two companies, Merck and Ciba, state they discovered the medication which became commercially available in 1959. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In 2008 it was the second most commonly used blood pressure medication in the United States. It is available as a generic drug and is relatively affordable.",""
Hydrochlorothiazide-d2 is the labeled analogue of Hydrochlorothiazide (H714560), a carbonic anhydrase inhibitor as a diuretic. Labeled Hydrochlorothiazide, intended for use as an internal standard for the quantification of Hydrochlorothiazide by GC- or LC-mass spectrometry.
6chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-d2-7-sulfonamide 1,1-Dioxide; Aquarius; Bremil-dd2;urizid-d2; Drenol-d2; Hidrchlortiazid-d2; Hydrex-d2; Oretc-d2; Pantemon-d2; Thiuretc-d2
Piala, J.J., et al.: J. Pharmcol. Exp. Ther., 134, 273 (1961), Deppeler, H.P., et al.: Anal. Profiles Drug Subs., 10, 405 (1981),
We normally respond within 8 hours.
This page contains information about Hydrochlorothiazide D2 Cas # 1219798-89-6 and its Stable Isotopes.
Hydrochlorothiazide D2 Hydrochlorothiazide D2 Worldwide Suppliers of Hydrochlorothiazide D2 https://www.clearsynth.com/en/CSO06662.html Stable Isotopes Clearsynth 1219798-89-6
Regular price: $500 In stock
Product rating: 9 Hydrochlorothiazide D2 based on 20 ratings
Keywords: Stable Isotopes 6chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-d2-7-sulfonamide 1,1-Dioxide; Aquarius; Bremil-dd2;urizid-d2; Drenol-d2; Hidrchlortiazid-d2; Hydrex-d2; Oretc-d2; Pantemon-d2; Thiuretc-d2 CS-O-06662 Hydrochlorothiazide D2 Hydrochlorothiazide 1219798-89-6 299.75 C7H6DClN3O4S2
Internal standard, Internal standard Hydrochlorothiazide, HPLC-MS method validation, HPLC-MS method validation Hydrochlorothiazide, LC-MS-MS method validation, LC-MS-MS method validation Hydrochlorothiazide, Deuterated internal standard, Deuterated internal standard Hydrochlorothiazide, Deuterated Hydrochlorothiazide, Deuterium labeled Hydrochlorothiazide, Quantitative bioanalytical methods, Quantitative bioanalytical methods Hydrochlorothiazide, Blood samples Hydrochlorothiazide, Blood concentrations, Heavy drugs, Analysis, Analysis Hydrochlorothiazide, Clinical diagnostic, Clinical diagnostic Hydrochlorothiazide, Dosing Hydrochlorothiazide, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945